GENEWIZ, Inc. Launches Ion Proton(TM) Services as Ion AmpliSeq(TM) Exome Certified Service Provider

GENEWIZ, Inc. Launches Ion Proton(TM) Services as Ion AmpliSeq(TM) Exome Certified Service Provider

ID: 303397

(firmenpresse) - SOUTH PLAINFIELD, NJ -- (Marketwired) -- 10/07/13 -- , leading global genomic service provider, has now become an Ion AmpliSeq™ Exome Certified Service Provider.

Administered by Life Technologies, "[the] Ion AmpliSeq™ Exome Certified Service Provider Program is a network of validated service providers that enables any researcher to get high quality exome sequence, using small amounts of input material and with rapid turnaround."

With the Ion Proton™, GENEWIZ can deliver exome sequencing and RNA-Seq projects rapidly and cost-effectively, without the requirement of multiplexing large numbers of samples per run.

"As a full-service next generation sequencing provider, offering services on the Ion Proton™ enables GENEWIZ to best optimize experiments based on our customers' project needs," stated Ginger Zhou, Head of NGS (U.S.), GENEWIZ, Inc. "As an Ion AmpliSeq™ Exome Certified Service Provider, we can deliver high-quality results in as few as 7 business days. In addition to rapid results, this certification endorses the consistent level of quality data and service customers can count on from GENEWIZ."

is a global contract research organization (CRO) specializing in genomic services, including DNA sequencing, gene synthesis, molecular biology, genomic, bioinformatics, and GxP/CLIA regulatory-compliant services. GENEWIZ leads the industry in outsourcing partnerships with pharmaceutical, biotechnology, clinical, academic, and government institutions.

Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; and Tokyo, Japan.



GENEWIZ, Inc.

Global Headquarters
115 Corporate Boulevard
South Plainfield, NJ 07080
+1-908-222-0711






Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Pharma-Bio Industry to Invest $4.3 Billion in Capital/MRO Project Starts in Fourth-Quarter 2013, an Industrial Info News Alert Threshold Pharmaceuticals Announces New Data on TH-302 to Be Presented at AACR-NCI-EORTC
Bereitgestellt von Benutzer: Marketwired
Datum: 07.10.2013 - 16:00 Uhr
Sprache: Deutsch
News-ID 303397
Anzahl Zeichen: 0

contact information:
Town:

SOUTH PLAINFIELD, NJ



Kategorie:

Biotech



Diese Pressemitteilung wurde bisher 228 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"GENEWIZ, Inc. Launches Ion Proton(TM) Services as Ion AmpliSeq(TM) Exome Certified Service Provider"
steht unter der journalistisch-redaktionellen Verantwortung von

GENEWIZ, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von GENEWIZ, Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z